Thiobenzoic Acid

Thiobenzoic Acid

SCHEMBL164093

CC(C)(OC(=S)c1ccccc1)c1ccccc1.OC(=S)c1ccccc1

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.47
ALOX15 P16050 1/20 0.47
MAPK1 P28482 1/20 0.45
CES1 P23141 1/20 0.36
CYP2C19 P33261 2/20 0.35
HIF1A Q16665 1/20 0.35
MAPT P10636 3/20 0.34
TDP1 Q9NUW8 2/20 0.33
ESR1 P03372 2/20 0.33
ESR2 Q92731 2/20 0.33
HPGD P15428 1/20 0.33
HTT P42858 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
HSP90AA1 P07900 1/20 0.33
CYP3A4 P08684 1/20 0.33
TSHR P16473 1/20 0.33
HSD17B10 Q99714 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
EPHX1 P07099 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Thiobenzoic Acid SCHEMBL15388584 0.98 ALDH1A1 (0.46) ALDH1A1ALOX15MAPK1CES1CYP2C19
SCHEMBL22772245 0.94 ALDH1A1 (0.52) ALDH1A1ALOX15MAPK1CES1CYP2C19
Thiobenzoic Acid SCHEMBL1524465 0.91 ALDH1A1 (0.43) ALDH1A1ALOX15MAPK1CES1MAPT
Thiobenzoic Acid SCHEMBL163805 0.89 ALDH1A1 (0.41) ALDH1A1ALOX15MAPK1CES1CYP2C19
Thiobenzoic Acid SCHEMBL11608595 0.88 ESR1 (0.40) ALDH1A1ALOX15MAPK1MAPTESR1
Thiobenzoic Acid SCHEMBL236902 0.83 ALDH1A1 (0.40) ALDH1A1ALOX15CYP2C19MAPTTDP1
Thiobenzoic Acid SCHEMBL28774864 0.83 ALDH1A1 (0.40) ALDH1A1ALOX15CYP2C19MAPTTDP1
Thiobenzoic Acid SCHEMBL15282107 0.79 ALDH1A1 (0.33) ALDH1A1ALOX15MAPK1CES1CYP2C19
SCHEMBL28458639 0.77 ALDH1A1 (0.44) ALDH1A1ALOX15MAPK1CES1CYP2C19
Thiobenzoic Acid SCHEMBL2320796 0.77 HPGD (0.47) ALDH1A1ALOX15MAPK1CES1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 240 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023099310-A1 PREPARATION OF HIGH SOLID CONTENT, SURFACTANT-FREE LATEX USING FUNCTIONAL AMPHIPHILIC WATERBORNE MACRO-RAFT AGENT BASF SE (DE) 2023-06-08 WO claimed
US-20080071003-A1 Method for Producing Molecularly Imprinted Polymers UNIVERSITY OF DORTMUND INFU (DE) 2008-03-20 US claimed
EP-1781711-A1 METHOD FOR PRODUCING MOLECULARLY IMPRINTED POLYMERS University of Dortmund Infu (DE) 2007-05-09 EP claimed
EP-1383828-A4 A METHOD OF TREATING THE SURFACE OF A SUBSTRATE POLYMER USEFUL FOR GRAFT POLYMERIZATION BIO LAYER PTY LTD (AU) 2006-10-04 EP claimed
WO-2006004536-A1 METHOD FOR PRODUCING MOLECULARLY IMPRINTED POLYMERS UNIVERSITY OF DORTMUND INFU (DE) 2006-01-12 WO claimed
US-6858309-B2 Methods of polymerization POLYMERAT PTY. LTD. (AU) 2005-02-22 US claimed
EP-1383828-A1 A METHOD OF TREATING THE SURFACE OF A SUBSTRATE POLYMER USEFUL FOR GRAFT POLYMERIZATION Polymerat Pty Ltd (AU) 2004-01-28 EP claimed
US-20030088028-A1 Methods of polymerization ANTEO TECHNOLOGIES PTY LTD (AU) 2003-05-08 US claimed
WO-2002079305-A1 A METHOD OF TREATING THE SURFACE OF A SUBSTRATE POLYMER USEFUL FOR GRAFT POLYMERIZATION POLYMERAT PTY LTD (AU) 2002-10-10 WO claimed
US-20260132298-A1 A METHOD FOR PRODUCING INTERFERENCE ELEMENTS BASF SE (DE) 2026-05-14 US disclosed
US-12624196-B2 Rubber composition, vulcanized object obtained from said rubber composition, and vulcanized molded object obtained from said rubber composition DENKA COMPANY LIMITED (JP) 2026-05-12 US disclosed
EP-2292668-B2 Process for preparing polymers and compositions thereof LUBRIZOL CORP (US) 2025-09-10 EP disclosed
US-20250269096-A1 FLUOROPOLYMER MEDICAL DEVICES UNOMEDICAL AS (DK) 2025-08-28 US disclosed
EP-4583933-A1 FLUOROPOLYMER MEDICAL DEVICES Unomedical A/S (DK) 2025-07-16 EP disclosed
US-20020022684-A1 Microgels and process for their preparation COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2002-02-21 US disclosed
US-20020019475-A1 Microgels and process for their preparation COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2002-02-14 US disclosed
US-20020019476-A1 Microgels and process for their preparation COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2002-02-14 US disclosed
EP-0910587-B1 POLYMERIZATION WITH LIVING CHARACTERISTICS DU PONT (US) 2001-12-12 EP disclosed
EP-0910587-A1 POLYMERIZATION WITH LIVING CHARACTERISTICS E.I. DU PONT DE NEMOURS AND COMPANY (US) 1999-04-28 EP disclosed
WO-1998001478-A1 POLYMERIZATION WITH LIVING CHARACTERISTICS E.I. DU PONT DE NEMOURS AND COMPANY (US) 1998-01-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260132298-A1 A METHOD FOR PRODUCING INTERFERENCE ELEMENTS COPE, COPB2, C9 ALDH1A1 1943/4885ALOX15 4306/4885MAPK1 1507/4885
US-12624196-B2 Rubber composition, vulcanized object obtained from said rubber composition, and vulcanized molded object obtained from said rubber composition ALG3, VCL, DNMT1 ALDH1A1 2251/4885ALOX15 1851/4885MAPK1 1582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.